期刊文献+

HDAC抑制剂MS-275诱导人肺腺癌细胞系A549基因表达谱分析 被引量:1

Analysis of Gene Expression Profile Induced by HDAC Inhibitor MS-275 in A549
下载PDF
导出
摘要 目的研究HDAC抑制剂MS-275对人肺腺癌A549细胞基因表达谱的影响,探讨MS-275抗肿瘤的分子机制。方法运用制备的包含8064个人类基因的cDNA芯片检测MS-275诱导人肺腺癌A549细胞基因表达谱的变化。结果MS-275(2μmo·lL-1)处理A549细胞16h后,cDNA芯片分析筛选出MS-275对A549细胞的影响基因803个,其中上调基因440个,下调基因363个,其中包括许多与细胞凋亡、细胞分化、DNA修复等相关基因如p21、DR6。结论MS-275通过外源性凋亡信号、内源性凋亡信号和细胞周期阻滞等多种分子机制诱导A549细胞凋亡。 Aim To investigate the effect of HDAC inhibitor MS-275 on the gene expression profile in A549 and explore the potential molecular mechanism of anti-cancer for MS-275. Methods A eDNA microarray containing 8 064 genes was used to detect the gene expression profile induced by MS-275 in A549. Results 440 up-regulated genes and 363 down-regulated genes were obtained in the gene expression profile for A549 treated with 2μLmol·L^-1 MS-275 for 16h. It showed that MS-275 regulated the genes of cell apoptosis, cell differentiation and DNA repair in A549 such as p21, DR6. Conclusion MS-275 induced the apoptosis of A549 cells by various molecular mechanisms such as extrinsic apoptosis pathway, intrinsic apoptosis pathway and cell cycle arrest.
出处 《解放军药学学报》 CAS 2008年第4期304-307,共4页 Pharmaceutical Journal of Chinese People's Liberation Army
关键词 MS-275 A549细胞 基因芯片 表达谱分析 MS-275 A549 cells Microarray Analysis of gene expression profile
  • 相关文献

参考文献12

  • 1Sakajiri S, Kumagai T, Kawamata N, et al. Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines[ J]. Exp Hematol ,2005,33 ( 1 ) :53 被引量:1
  • 2His L,Xi X,Lotan R, et al. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apop tosis via induction of 15-lipoxygenase-1 in colorectal cancer cells [ J ]. Cancer Res , 2004,64 (23) :8778 被引量:1
  • 3Hu E, Dul E, Sung CM, et al. Identification of novel isoform-selective inhibitors within class 1 histone deacetylase[ J]. J Pharmaco Exp Ther ,2003,307(2) :720 被引量:1
  • 4Kummar S, Gutierrez M, Gardner ER, et al. Phase I trial of MS- 275, a histone deacetylase inhibitor, administered weekly in refractory solid tumors and lymphoid malignancies [ J ]. Clin Cancer Res ,2007,13 ( 18 ) :5411 被引量:1
  • 5Glazer KB,Staver MJ,Waring JF, et al. Gene expression profding of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma eell lines[ J]. Molecular Cancer Therapeutics ,2003,2(2) :151 被引量:1
  • 6Schroeder TM, Nair AK, Staggs R, et al. Gene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors[ J]. BMC Genomics ,2007,362(8) :1 被引量:1
  • 7Lee H, Lee S,Baek M, et al. Expression profile analysis of trichostatin A in human gastric cancer cells[J]. Biotech Lett ,2002,24(5) :377 被引量:1
  • 8Mariadason J, Comer G, Augenlicht L. Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer[ J ]. Cancer Res, 2000,60(16) :4561 被引量:1
  • 9Vidal A, Koff A. Cell-cycle inhibitors: three families united by a common cause [J].Gene, 2000,247 ( 1 ) : 1 被引量:1
  • 10Xu W, Ngo L, Perez G, et al. Intrinsic apoptotic and thioredoxin pathways in human prostate cancer cell response to histone deacetylase inhibitor[J]. Proc Natl Acad Sci USA ,2006,103(42) :15540 被引量:1

同被引文献5

  • 1Michael Dickinson,Ricky W. Johnstone,H. Miles Prince.Histone deacetylase inhibitors: potential targets responsible for their anti-cancer effect[J]. Investigational New Drugs . 2010 (1) 被引量:1
  • 2Olaia Martínez-Iglesias,Lidia Ruiz-Llorente,Ruth Sánchez-Martínez,Laura García,Alberto Zambrano,Ana Aranda.Histone deacetylase inhibitors: mechanism of action and therapeutic use in cancer[J]. Clinical and Translational Oncology . 2008 (7) 被引量:1
  • 3Dong ZX,,Tan RK,Cao J,et al.Discovery ofpolyoxometalate-based HDAC inhibitors with profoundanticancer activity in vitro and in vivo. EuropeanJournal of Medicinal Chemistry . 2011 被引量:1
  • 4Sancheza E,Shena J,Steinberga J,et al.The histonedeacetylase inhibitor LBH589 enhances the anti-myeloma effects of chemotherapy in vitro and in vivo. Leukemia Research . 2011 被引量:1
  • 5Zou G,Gao Z,Wang J,Zhang Y,Ding H,Huang J, et ai.Deoxyelephan-topin inhibits cancer cell proliferation and functions as a selective partial agonist against PPARgamma. Biochemical Pharmacology . 2008 被引量:1

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部